2014至2020年美国国际妊娠代孕趋势与结局
这项回顾性队列研究分析了2014至2020年美国辅助生殖技术中40,177例向妊娠代孕者移植胚胎的周期,其中32%为国际意向父母。国际意向父母周期数及占比从2014年(n=2758,22.0%)逐年增至2019年(n=4905,39.8%),2020年回落至n=4713(31.8%)。国际与美国意向父母的活产率(调整风险比1.01,95%CI 1.00-1.03)和多胎妊娠率(调整风险比1.00,95%CI 0.94-1.06)相似。
要点
- 2014至2020年美国40,177例代孕胚胎移植中32%为国际意向父母。
- 国际周期占比从2014年22.0%升至2019年39.8%,2020年降至31.8%。
- 国际与美国意向父母的活产和多胎妊娠率无显著差异。
核心结论
- 越来越多的国际意向父母在美国使用妊娠代孕,并更频繁使用增加成本的专门治疗技术。
- 作者认为这一增长可能源于限制性国际商业代孕法律及生殖医学专业知识的可及性增加。
- 作者认为鉴于这一人群增长,有必要继续审视跨境生殖治疗的规模及法律与伦理考量。
研究设计与样本
- 回顾性队列研究,数据来自2014至2020年美国辅助生殖技术周期中向妊娠代孕者移植胚胎并报告至美国辅助生殖技术学会临床结局报告系统的周期。
- 比较对象为国际意向父母与美国意向父母。
- 主要结局指标为周期特征、地理分布和产科结局。
主要发现
- 2014至2020年共40,177例向妊娠代孕者的胚胎移植,其中32%为国际意向父母。
- 国际意向父母代孕周期数及占比从2014年(n=2758,22.0%)增至2019年(n=4905,39.8%),2020年降至n=4713(31.8%)。
- 2019至2020年间国际意向父母代孕周期下降幅度大于美国意向父母(3.9% vs. 32.2%)。
- 国际意向父母更多为男性(41.3% vs. 19.6%)、年龄大于42岁(33.9% vs. 26.2%)及亚裔(65.6% vs. 16.5%),主要来自中国(41.7%)、法国(9.2%)和西班牙(8.5%)。
- 国际意向父母的妊娠代孕者更多小于30岁(42.8% vs. 29.1%)及西班牙裔(28.6% vs. 11.7%),周期更常用供卵(67.1% vs. 43.5%)、卵胞浆内单精子注射(72.8% vs. 55.4%)和植入前遗传学检测(79.0% vs. 55.8%)。
关键数值与推荐
- 活产率:国际意向父母与美国意向父母调整风险比1.01(95%CI 1.00-1.03)。
- 多胎妊娠率:国际意向父母与美国意向父母调整风险比1.00(95%CI 0.94-1.06)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe characteristics, trends, and outcomes of international gestational surrogacy cycles in the United States (US). DESIGN: Retrospective cohort study. SETTING: All assisted reproductive technology cycles in the US reported to the Society for Assisted Reproductive Technology Clinic Outcome Reporting Systems that included an embryo transfer to a gestational carrier from 2014 to 2020. PATIENTS: International vs. US intended parents. MAIN OUTCOME MEASURES: Cycle characteristics, geographic distributions, and obstetrical outcomes. RESULTS: Of 40,177 embryo transfers to a gestational carrier from 2014 to 2020, 32% were for international intended parents. The number and percent of international intended parents' gestational carrier cycles increased each year from 2014 (n = 2758, 22.0%) to 2019 (n = 4905, 39.8%) with a decrease in 2020 (n = 4713, 31.8%). Compared with cycles for US intended parents, there was a larger decrease in gestational carrier cycles between 2019 and 2020 for international intended parents (3.9% vs. 32.2%). International intended parents were more likely to be male sex (41.3% vs. 19.6%), older than 42 years (33.9% vs. 26.2%) and identify as Asian race (65.6% vs. 16.5%). International intended parents were largely from China (41.7%), followed by France (9.2%) and Spain (8.5%). Gestational carriers for international intended parents were more commonly younger than 30 years (42.8% vs. 29.1%) and identified as Hispanic race (28.6% vs. 11.7%) compared with gestational carriers for US intended parents. Cycles with international intended parents were more likely to use donor eggs (67.1% vs. 43.5%), intracytoplasmic sperm injection (72.8% vs. 55.4%), and preimplantation genetic testing (79.0% vs. 55.8%). Cycles with international and US intended parents had similar obstetrical outcomes, including live birth (adjusted risk ratio 1.01, 95% confidence interval 1.00-1.03) and multiple pregnancy (adjusted risk ratio 1.00, 95% confidence interval 0.94-1.06) rates. CONCLUSION: An increasing number of international intended parents are utilizing gestational surrogacy in the US and more frequently using cost-enhancing specialized treatment techniques. This increase is potentially because of restrictive international commercial surrogacy laws and the increased availability of reproductive medical expertise. Given this growing demographic, continued examination of the volume of cross-border reproductive treatment, as well as the legal and ethical considerations, is warranted.
引用
- Herweck A, DeSantis C, Shandley LM, et al. International gestational surrogacy in the United States, 2014-2020. Fertil Steril. 2024. PMID: 38176517. doi:10.1016/j.fertnstert.2023.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。